KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Deferred Taxes (2022 - 2024)

Historic Deferred Taxes for Nektar Therapeutics (NKTR) over the last 3 years, with Q3 2024 value amounting to -$31000.0.

  • Nektar Therapeutics' Deferred Taxes fell 10666.67% to -$31000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.7 million, marking a year-over-year increase of 9929.74%. This contributed to the annual value of -$140000.0 for FY2023, which is 10516.99% down from last year.
  • According to the latest figures from Q3 2024, Nektar Therapeutics' Deferred Taxes is -$31000.0, which was down 10666.67% from $57000.0 recorded in Q2 2024.
  • Nektar Therapeutics' Deferred Taxes' 5-year high stood at $2.7 million during Q4 2022, with a 5-year trough of -$1.8 million in Q1 2023.
  • Over the past 3 years, Nektar Therapeutics' median Deferred Taxes value was -$21000.0 (recorded in 2023), while the average stood at $319500.0.
  • Data for Nektar Therapeutics' Deferred Taxes shows a peak YoY increase of 31111.11% (in 2024) and a maximum YoY decrease of 10666.67% (in 2024) over the last 5 years.
  • Nektar Therapeutics' Deferred Taxes (Quarter) stood at $2.7 million in 2022, then plummeted by 36.71% to $1.7 million in 2023, then tumbled by 101.81% to -$31000.0 in 2024.
  • Its last three reported values are -$31000.0 in Q3 2024, $57000.0 for Q2 2024, and -$38000.0 during Q1 2024.